- Home
- PMTS vs MGTX Comparison
PMTS vs MGTX Comparison
Compare PMTS & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- MGTX
- Stock Information
- Founded
- PMTS 2007
- MGTX 2015
- Country
- PMTS United States
- MGTX United States
- Employees
- PMTS N/A
- MGTX N/A
- Industry
- PMTS Finance Companies
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMTS Finance
- MGTX Health Care
- Exchange
- PMTS Nasdaq
- MGTX Nasdaq
- Market Cap
- PMTS 327.9M
- MGTX 520.8M
- IPO Year
- PMTS 2015
- MGTX N/A
- Fundamental
- Price
- PMTS $22.14
- MGTX $8.47
- Analyst Decision
- PMTS Strong Buy
- MGTX Strong Buy
- Analyst Count
- PMTS 4
- MGTX 2
- Target Price
- PMTS $36.75
- MGTX $24.00
- AVG Volume (30 Days)
- PMTS 51.9K
- MGTX 541.8K
- Earning Date
- PMTS 08-04-2025
- MGTX 08-11-2025
- Dividend Yield
- PMTS N/A
- MGTX N/A
- EPS Growth
- PMTS 1.33
- MGTX N/A
- EPS
- PMTS 1.58
- MGTX N/A
- Revenue
- PMTS $491,426,000.00
- MGTX $34,508,000.00
- Revenue This Year
- PMTS $14.61
- MGTX $365.04
- Revenue Next Year
- PMTS $12.49
- MGTX $73.18
- P/E Ratio
- PMTS $14.04
- MGTX N/A
- Revenue Growth
- PMTS 12.81
- MGTX 203.23
- 52 Week Low
- PMTS $18.46
- MGTX $3.85
- 52 Week High
- PMTS $35.19
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- PMTS 42.55
- MGTX 76.43
- Support Level
- PMTS $22.68
- MGTX $6.31
- Resistance Level
- PMTS $23.41
- MGTX $8.75
- Average True Range (ATR)
- PMTS 0.77
- MGTX 0.45
- MACD
- PMTS -0.13
- MGTX 0.19
- Stochastic Oscillator
- PMTS 2.04
- MGTX 89.55
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.